Melatonin is a hormone that helps in regulating the sleep-wake cycle and is produced naturally in the body. It is synthetically produced in a laboratory for treating short-term treatment of insomnia. It has antioxidant properties which expand its applications across pharmaceuticals, food & beverages, and dietary supplements.
Market Dynamics
Increasing use of melatonin in the production of bio-based spray polyurethane foam (SPF) for construction & building insulation is expected to provide potential opportunities in the near future. This is attributed to the growth in the construction industry due to rapidly growing urbanization and industrialization around the globe coupled with the increasing populations. Thus growing demand for melatonin from the construction industry is expected to propel the market growth.
Growth in the food &beverage industry is expected to augment the market growth of the melatonin. Increasing consumer spending on the food products coupled with the growing demand for various food products is expected to propel the market growth of the melatonin. According to the United States Department of Agriculture Economic Research Service, in 2019, food spending by U.S. consumers, businesses and government entities was valued $1.77 trillion.
Key features of the study:
Detailed Segmentation:
Global Melatonin Market, By Application:
Global melatonin market, By Region:
“*” marked represents similar segmentation in other categories in the respective section.
Market Dynamics
Increasing use of melatonin in the production of bio-based spray polyurethane foam (SPF) for construction & building insulation is expected to provide potential opportunities in the near future. This is attributed to the growth in the construction industry due to rapidly growing urbanization and industrialization around the globe coupled with the increasing populations. Thus growing demand for melatonin from the construction industry is expected to propel the market growth.
Growth in the food &beverage industry is expected to augment the market growth of the melatonin. Increasing consumer spending on the food products coupled with the growing demand for various food products is expected to propel the market growth of the melatonin. According to the United States Department of Agriculture Economic Research Service, in 2019, food spending by U.S. consumers, businesses and government entities was valued $1.77 trillion.
Key features of the study:
- This report provides in-depth analysis of the global melatonin market and provides market size (US$ Million & Tons) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by key players
- This study also provides impact analysis of Coronavirus (Covid-19) pandemic on global melatonin market.
- It profiles key players in the global melatonin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study Natrol Inc., Neurim Pharmaceuticals Ltd., Pulse Pharmaceuticals Pvt. Ltd., Flynn Pharma Ltd., Fidia Farmaceutici S.P.A., Aspen Pharmacare Holdings Ltd., Schiff Nutrition International Inc., Solal Technologies (Pty) Ltd., Rexall Sundown, Inc., and Bebida Beverage Co.
- Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology upgradation, market expansion, and marketing tactics
- The global melatonin market report caters to various stakeholders in this industry including investors, suppliers, global soy and milk protein ingredients manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global melatonin market
Detailed Segmentation:
Global Melatonin Market, By Application:
- Dietary Supplements
- Medicine
- Food & Beverages
- Others
Global melatonin market, By Region:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East
- Africa
- Company Profiles
- Natrol Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Neurim Pharmaceuticals Ltd.
- Pulse Pharmaceuticals Pvt. Ltd.
- Flynn Pharma Ltd.
- Fidia Farmaceutici S.P.A.
- Aspen Pharmacare Holdings Ltd.
- Schiff Nutrition Internatoional Inc.
- Solal Technologies (Pty) Ltd.
- Rexall Sundown, Inc
- Bebida Beverage Co.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Melatonin Market - Impact of Coronavirus (Covid-19) Pandemic
5. Global Melatonin Market, By Application, 2017 - 2027 (US$ Million & Tons)
6. Global Melatonin Market, By Region, 2017- 2027 (US$ Million & Tons)
7. Competitive Landscape
8. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Natrol Inc.
- Neurim Pharmaceuticals Ltd.
- Pulse Pharmaceuticals Pvt. Ltd.
- Flynn Pharma Ltd.
- Fidia Farmaceutici S.P.A.
- Aspen Pharmacare Holdings Ltd.
- Schiff Nutrition Internatoional Inc.
- Solal Technologies (Pty) Ltd.
- Rexall Sundown, Inc
- Bebida Beverage Co.